1 / 36

Advances in Diabetic Macular Edema

Advances in Diabetic Macular Edema. Program Goal. Introduction. RIDE/RISE: Study Designs. RIDE/RISE: Subjects Gaining ≥ 15 ETDRS Letters at Month 36. RIDE/RISE: Serious Adverse Events. RIDE/RISE: Mean Change in BCVA*. RIDE/RISE: Mean Change in OCT CFT.

erasmus-hawkins
Download Presentation

Advances in Diabetic Macular Edema

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Advances in Diabetic Macular Edema

  2. Program Goal

  3. Introduction

  4. RIDE/RISE: Study Designs

  5. RIDE/RISE: Subjects Gaining ≥ 15 ETDRS Letters at Month 36

  6. RIDE/RISE: Serious Adverse Events

  7. RIDE/RISE: Mean Change in BCVA*

  8. RIDE/RISE: Mean Change in OCT CFT

  9. RIDE/RISE: Retinopathy Severity Scale Changes at Month 24

  10. BOLT: Bevacizumab vs Modified Laser Treatment

  11. Treatment Burden

  12. The Role of Laser

  13. DA VINCI: Mean Change in Visual Acuity: ETDRS Letter Change

  14. DA VINCI Study Design

  15. Corticosteroids

  16. The Role of Steroids

  17. Case #1: OCT OD

  18. Case #1: Treatment Approach

  19. Case #1: Monthly Bevacizumab and Focal Treatment

  20. Case #1: Treatment Approach (cont)

  21. Case #2: A 52-Year-Old With Fundus Appearance

  22. Case #2: OD 20/30-1, OS 20/40-2

  23. Case #2: Management Approach

  24. Wide-Field Angiography: Diabetic Retinopathy

  25. Case #2: OD 20/80-1, OS 20/80+1

  26. Case #2: Management Approach (cont)

  27. Approaches to Cataract

  28. Upcoming Research

  29. Ocriplasmin

  30. Abbreviations

More Related